Basel Medical (BMGL) Shares Outstanding (Weighted Average) (2023 - 2025)

Basel Medical's Shares Outstanding (Weighted Average) history runs 3 years deep, the most recent figure standing at $14.4 million for Q2 2025.

• In Q2 2025, Shares Outstanding (Weighted Average) rose 20.16% year-over-year to $14.4 million; the TTM figure through Jun 2025 stood at $14.4 million (up 20.16% YoY), while the FY2025 annual figure was $25.6 million, up 113.22% from the prior year.
• Shares Outstanding (Weighted Average) came in at $14.4 million for Q2 2025 at Basel Medical, up from $12.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $14.4 million in Q2 2025 to a low of $12.0 million in Q2 2024.
• A 3-year average of $12.7 million and a median of $12.1 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) grew 1.5% in 2024 and climbed 20.16% in 2025, its largest moves.
• Basel Medical's Shares Outstanding (Weighted Average) stood at $12.0 million in 2023, then grew by 1.5% to $12.2 million in 2024, then climbed by 18.14% to $14.4 million in 2025.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $14.4 million, $12.2 million, and $12.0 million for Q2 2025, Q4 2024, and Q2 2024 respectively.

Peer Comparison